NYSE:BMR

Biomed Realty Trust (BMR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$5.51
$6.20
50-Day Range
N/A
52-Week Range
$17.94
$25.08
Volume
543,922 shs
Average Volume
1.96 million shs
Market Capitalization
$77.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BMR stock logo

About Biomed Realty Trust Stock (NYSE:BMR)

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

BMR Stock News Headlines

Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
3 Stock Winners That Are Up 400% or More in 2024
Brandywine Realty Trust
Boston Diversity, Equity and Inclusion News
BioMed Realty Announces 2023 ESG Achievements
Beamr Issues Q3-2023 CEO Letter to Shareholders
See More Headlines
Receive BMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/28/2015
Today
4/26/2024
Next Earnings (Estimated)
6/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Office REITs
CUSIP
09063H10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.91 million
Book Value
$0.80 per share

Miscellaneous

Free Float
12,664,000
Market Cap
$77.80 million
Optionable
Not Optionable
Beta
6.07
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Greg N. Lubushkin (Age 62)
    Chief Financial Officer
  • James R. Berens (Age 61)
    President of Wexford Science & Technology
  • Jonathan Paul Klassen (Age 39)
    Executive Vice President, General Counsel, Secretary
  • John P. Bonanno (Age 49)
    Executive Vice President, Leasing & Development
  • Karen A. Sztraicher (Age 51)
    Executive Vice President - Asset Management

BMR Stock Analysis - Frequently Asked Questions

When is Biomed Realty Trust's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024.
View our BMR earnings forecast
.

How were Biomed Realty Trust's earnings last quarter?

Biomed Realty Trust Inc (NYSE:BMR) released its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.04. The real estate investment trust earned $178.01 million during the quarter, compared to analyst estimates of $167.08 million. The company's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.38 EPS.

What other stocks do shareholders of Biomed Realty Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomed Realty Trust investors own include Gilead Sciences (GILD), Intel (INTC), Kinder Morgan (KMI), Ventas (VTR), Verizon Communications (VZ), Welltower (WELL), Archer-Daniels-Midland (ADM), CVS Health (CVS), Dominion Energy (D) and Extra Space Storage (EXR).

When did Biomed Realty Trust IPO?

Biomed Realty Trust (BMR) raised $8 million in an initial public offering (IPO) on Tuesday, February 28th 2023. The company issued 1,950,000 shares at a price of $4.00 per share.

This page (NYSE:BMR) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners